Menopause and sexuality: prevalence of symptoms and impact on quality of life.
about
Hormone therapy for sexual function in perimenopausal and postmenopausal womenHormone therapy for sexual function in perimenopausal and postmenopausal womenSexual Problems among Japanese Women: Data from an Online HelplineDevelopment and evaluation of Korean version of Quality of Sexual Function (QSF-K) in healthy Korean womenA systems biology approach investigating the effect of probiotics on the vaginal microbiome and host responses in a double blind, placebo-controlled clinical trial of post-menopausal womenUrogenital disorders associated with oestrogen deficiency: the role of promestriene as topical oestrogen therapy.Management of hypoactive sexual desire disorder in women: current and emerging therapiesPsychometric evaluation of the Midlife Women's Symptom Index in multiethnic groups.Duration of menopausal hot flushes and associated risk factorsInfluence of habitual physical activity on the symptoms of climacterium/menopause and the quality of life of middle-aged women.The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophyQuality of life of postmenopausal women and their spouses: a community-based studyTreatment of the genitourinary syndrome of menopause.An update on drugs for the treatment of menopausal symptoms.Oophorectomy: the debate between ovarian conservation and elective oophorectomyAttitudes About Sexual Activity Among Postmenopausal Women in Different Ethnic Groups: A Cross-sectional Study in Jahrom, IranVulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey.Menopause and crisis? Fake or real: comprehensive search to the depth of crisis experienced: a mixed-method studySexual function in older women after oophorectomy.Evaluation of sexual attitude and sexual function in menopausal age; a population based cross-sectional study.The Relationship between Physical Activity and General Health among Menopausal Women in Ahvaz, Iran.Pharmacogenomics and sexuality: a vision.Ultra-low-dose vaginal estrogen tablets for the treatment of postmenopausal vaginal atrophy.Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause.Treatment of vaginal atrophy.Factors Affecting Sexual Function in Midlife Women: Results from the Midlife Women's Health Study.Sexual health in Spanish postmenopausal women presenting at outpatient clinics.Vulvar and vaginal atrophy as viewed by the Spanish REVIVE participants: symptoms, management and treatment perceptions.Female sexual function varies over time and is dependent on partner-specific factors: a population-based longitudinal analysis of six sexual function domains.A negative view of menopause: does the type of symptom matter?Medical and patient attitude towards vaginal atrophy: the AGATA study.Factors Affecting Sexual Activity in Midlife Women: Results from the Midlife Health Study.Views and Experiences of Malaysian Family Medicine Trainees of Female Sexual Dysfunction.Prevalence and Determinants of Premature Menopause among Indian Women: Issues and Challenges Ahead.Sex, women and the menopause: are specialist trainee doctors up for it? A survey of views and attitudes of specialist trainee doctors in Community Sexual & Reproductive Health and Obstetrics & Gynaecology around sexuality and sexual healthcare in thEducation Based on Theory of Planned Behavior over Sexual Function of Menopausal Women in IranFactors associated with menopausal symptoms among middle-aged registered nurses in Beijing.Assessment of sexuality after hysterectomy using the Female Sexual Function Index.Relationship between menopausal symptoms and sexual dysfunction among married Turkish women in 40-65 age group.The American-European difference in vulvar and vaginal atrophy views: a lesson from the REVIVE Survey.
P2860
Q24202201-F12276E6-4E18-44A6-9514-0C652D28A793Q24203764-B88CCA02-040E-46C1-A1B7-3BF4D993E88AQ31038968-C6E536A8-0493-4776-98EA-F2627970318FQ33749147-728E0B32-40D2-42E0-91F8-5F86319336D8Q34050627-314492D9-42BC-4176-AC4B-64405045DE6EQ34108946-CCC91DA6-A856-45FD-B195-3C6AAD177376Q34272161-0253495F-6655-41CB-B4D2-3560B0F94AAAQ34567567-379C0C89-257B-4C04-903E-F721AF8C56B9Q34893335-9B016EB3-FE35-4234-AABF-53A7B4539D58Q35562063-CCA41A24-0755-4345-AF6A-862368E90837Q35626394-3E8AD039-AFD7-430A-AD62-7EC39904AA1DQ35638630-649F75FA-5972-40E7-95C3-449289718A18Q35772318-28C22BB1-84BB-4B9C-AA6D-41C22112E2A0Q35784054-278A4172-465A-4EA2-B9FB-2720F20E86D3Q36445807-9F210865-A336-48EF-B357-7CEC3C4FCE54Q36626614-AD199FA2-4C20-4FC5-9015-08467175C13FQ36762551-B285206B-3655-4FFC-829E-F056DD621D5FQ36779593-C43429C6-28B8-4EAC-B261-BD833D05D0F0Q36781629-CC4900E9-E579-401C-A93E-1B4B2221F412Q37615449-AAE9864D-FDDD-4393-AC48-CCCA175280B0Q37641362-9E6BDC01-4EAC-4F55-A0E9-F616C762D680Q38121154-0DEB4E30-381F-4DA6-9FA0-EB5D3634918DQ38121156-D79CCA79-0D8D-417B-95F6-26044E1FB577Q38178431-16F7C083-5B15-4E8D-924A-A50CF51441FDQ38193877-DF8DC738-A091-47D3-ABBB-CE31FF7FC68CQ38823071-82357A67-0902-46DC-B9F0-DC12F3520B73Q38989634-89732EDC-84F9-4147-8DFE-FCF3441A5895Q39161834-4E5064D9-237A-4F73-B4C3-E23ACB39E3E9Q39263282-5A3BEE3F-DA13-43B3-AB12-3BBECE9DBC39Q39267153-6CBE9311-22BA-416E-98CA-B7CF19A4AFC5Q39295958-00305C45-9EAA-4568-8BB0-29D377D7D189Q39366743-0245FF22-2AF6-4D32-A5FF-773397857B19Q39511281-4500AECB-C1EF-489E-9D9D-DECC67CBDB3AQ40456106-0D49CA65-A8DD-49F0-BFCE-FBCCD9203089Q41458916-05853C22-8D6C-47FB-9CD4-D70E5E99ED21Q41977200-6CAA2CF0-742A-45F2-B231-1A528C6C755FQ44023014-7972AF6C-BCB0-43D1-AC7F-5B3339898E74Q44094210-A1BB0D96-CBEF-4D19-A5A2-BDE387189FA3Q44442599-2D7592DA-43EE-45F4-BA86-266C713F19ECQ45951188-A7F811FC-A753-49B8-A676-E3B1E4FD348D
P2860
Menopause and sexuality: prevalence of symptoms and impact on quality of life.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Menopause and sexuality: prevalence of symptoms and impact on quality of life.
@en
Menopause and sexuality: prevalence of symptoms and impact on quality of life.
@nl
type
label
Menopause and sexuality: prevalence of symptoms and impact on quality of life.
@en
Menopause and sexuality: prevalence of symptoms and impact on quality of life.
@nl
prefLabel
Menopause and sexuality: prevalence of symptoms and impact on quality of life.
@en
Menopause and sexuality: prevalence of symptoms and impact on quality of life.
@nl
P1433
P1476
Menopause and sexuality: prevalence of symptoms and impact on quality of life.
@en
P2093
Michèle Lachowsky
Rossella E Nappi
P304
P356
10.1016/J.MATURITAS.2009.03.021
P577
2009-05-21T00:00:00Z